Skip to main content
. 2021 May 26;11:11051. doi: 10.1038/s41598-021-90438-6

Figure 3.

Figure 3

Oxaloacetate treatment from the symptomatic stage delays the onset of limb paralysis (neurological score of 3) of SOD1G93A mice. (A) Oxaloacetate treatment from the presymptomatic stage (60 days old, red) did not alter the median age of onset of limb paralysis of SOD1G93A mice compared to the control group of non-injected SOD1G93A mice (black, p = 0.1793, log-rank test). (B) Oxaloacetate treatment from the symptomatic stage (110 days old, blue) significantly delayed the median age of onset for limb paralysis by seven days (p = 0.0157, log-rank test). The graphs show the Kaplan–Meier curve with n = 12 mice per group. These graphs contain mice that are identical to the mice in Fig. 1.